| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6066339 | KING PHARMS LLC | Oral morphine multiparticulate formulation |
Nov, 2017
(6 years ago) | |
Avinza is owned by King Pharms Llc.
Avinza contains Morphine Sulfate.
Avinza has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Avinza are:
- US6066339
Avinza was authorised for market use on 20 March, 2002.
Avinza is available in capsule, extended release;oral dosage forms.
The generics of Avinza are possible to be released after 25 November, 2017.
Drugs and Companies using MORPHINE SULFATE ingredient
Market Authorisation Date: 20 March, 2002
Treatment: NA
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
How can I launch a generic of AVINZA before it's drug patent expiration?
More Information on Dosage
AVINZA family patents
